C. P. Eng
Impact in
- Transplantation top 10%
- Renal Transplantation Outcomes and Treatments
-
- PI3K/AKT/mTOR signaling in cancer
- Signaling Pathways in Disease
- Cancer therapeutics and mechanisms
- Polyamine Metabolism and Applications
Papers in
-
- Cancer therapeutics and mechanisms 4
- Oncology 8
- Lung Cancer Research Studies 3
- Co-authors
- Suren N. Sehgal (3 shared papers)Claude Vézina (1 shared paper)Joseph F. Morgan (11 shared papers)K Singh (2 shared papers)Joseph P. Concannon (5 shared papers)Shawn J. Stachel (1 shared paper)Frances C. Nelson (1 shared paper)S. Rakhit (1 shared paper)
- Journals
- Canadian Journal of Microbiology (4 papers)The Journal of Antibiotics (3 papers)Journal of Clinical Oncology (3 papers)International Journal of Radiation Oncology*Biology*Physics (2 papers)JNCI Journal of the National Cancer Institute (2 papers)
- Partner nations
- CanadaUnited States
In The Last Decade
C. P. Eng
24 papers receiving 391 citations
Peers
Comparison fields: 5 of 77
- Transplantation 28
- Molecular Biology 266
- Toxicology 13
- Immunology 73
- Oncology 83
Countries citing papers authored by C. P. Eng
This map shows the geographic impact of C. P. Eng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. P. Eng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. P. Eng more than expected).
Fields of papers citing papers by C. P. Eng
This network shows the impact of papers produced by C. P. Eng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. P. Eng. The network helps show where C. P. Eng may publish in the future.
Co-authors
The 25 scholars most cited alongside C. P. Eng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1984 | 260 | |
| 2 | 1999 | 21 | |
| 3 | 1970 | 18 | |
| 4 | 1983 | 17 | |
| 5 | 1983 | 16 | |
| 6 | Lymphocyte mitogen stimulation studies for patients with lung cancer: evaluation of prognostic significance of preirradiation therapy studies. | 1977 | 12 |
| 7 | 1970 | 10 | |
| 8 | 1991 | 9 | |
| 9 | 1972 | 9 | |
| 10 | 1972 | 9 | |
| 11 | 1977 | 7 | |
| 12 | 1969 | 6 | |
| 13 | 1970 | 5 | |
| 14 | 2010 | 3 | |
| 15 | 1971 | 3 | |
| 16 | 1970 | 3 | |
| 17 | 1972 | 2 | |
| 18 | 2005 | 2 | |
| 19 | 1995 | 2 | |
| 20 | 2012 | 2 |
About C. P. Eng
C. P. Eng is a scholar working on Molecular Biology, Oncology, Immunology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 26 papers that have together received 421 indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (4 papers), Cancer Research and Treatments (4 papers), Lung Cancer Treatments and Mutations (4 papers), Immunotherapy and Immune Responses (4 papers), Toxin Mechanisms and Immunotoxins (3 papers), Bioactive Compounds and Antitumor Agents (3 papers), Lung Cancer Research Studies (3 papers) and Microbial Natural Products and Biosynthesis (2 papers). The work is most often cited by research in Transplantation (28 citations), Molecular Biology (266 citations), Toxicology (13 citations), Immunology (73 citations) and Oncology (83 citations). C. P. Eng has collaborated with scholars based in Canada and United States. Frequent co-authors include Suren N. Sehgal, Claude Vézina, Joseph F. Morgan, K Singh, Joseph P. Concannon, Shawn J. Stachel, Frances C. Nelson, S. Rakhit, Milton H. Dalbow and Maheep Bhatnagar. Their work appears in journals such as Canadian Journal of Microbiology, The Journal of Antibiotics, Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics and JNCI Journal of the National Cancer Institute.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.